Schizophrenia Spectrum Disorders clinical trials

Explore recruiting schizophrenia spectrum disorders clinical trials.

Recruiting schizophrenia spectrum disorders studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Schizophrenia Spectrum Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Enhancing social skills in schizophrenia spectrum disorders – two-arm, double-blind, randomized clinical trial investigating oxytocin vs. placebo as an add-on to an individualized psychosocial treatment (OXY-APS)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabolic control in antipsychotic-using patients (STABIL-NOR – study)

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Schizophrenia Spectrum Disorders trials by city

Schizophrenia Spectrum Disorders clinical trials

Recruiting schizophrenia spectrum disorders studies right now

The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Comparing Antipsychotic Medications in LBD Over Time

The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours

Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis

Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

Also recruiting in Europe

Enhancing social skills in schizophrenia spectrum disorders – two-arm, double-blind, randomized clinical trial investigating oxytocin vs. placebo as an add-on to an individualized psychosocial treatment (OXY-APS)

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabolic control in antipsychotic-using patients (STABIL-NOR – study)

Schizophrenia Spectrum Disorders trials by city

Other conditions